Publication | Closed Access

Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis

Immunotherapy TrialsOverall SurvivalMedicineImmunologyBronchial NeoplasmImmune Checkpoint InhibitorResponse RateCancer TreatmentOncologyRadiation OncologyLung Cancer